What are the management strategies for Acute Respiratory Distress Syndrome (ARDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ARDS Management

Immediately implement lung-protective ventilation with tidal volumes of 4-8 mL/kg predicted body weight and plateau pressure <30 cmH₂O in all mechanically ventilated ARDS patients, as this is the only intervention proven to reduce mortality regardless of ARDS etiology. 1, 2, 3

Severity Classification and Initial Assessment

  • Classify ARDS severity using the Berlin Definition based on PaO₂/FiO₂ ratio: mild (200-300 mmHg), moderate (100-200 mmHg), severe (<100 mmHg) 1, 2, 3
  • Confirm bilateral pulmonary opacities on chest imaging, acute onset within one week of known insult, and respiratory failure not fully explained by cardiac failure or fluid overload 3, 4

Respiratory Support Strategy by Severity

Mild ARDS (PaO₂/FiO₂ 200-300 mmHg)

  • Consider high-flow nasal cannula (HFNC) at 30-40 L/min with FiO₂ 50-60% over conventional oxygen therapy, but only with continuous ICU monitoring 1, 3
  • Noninvasive ventilation may be attempted only if SAPS II score <34, patient is hemodynamically stable, alert, cooperative, and ARDS is not caused by pneumonia 3
  • Proceed to early intubation in a controlled setting if deterioration occurs within 1 hour, FiO₂ >70%, flow >50 L/min, or Rapid Shallow Breathing Index >105 breaths/min/L 3

Moderate to Severe ARDS (PaO₂/FiO₂ <200 mmHg)

  • Proceed directly to mechanical ventilation rather than attempting noninvasive support, as failure rates are high 3

Mechanical Ventilation Protocol

Core Lung-Protective Settings (All Patients)

  • Set tidal volume at 4-8 mL/kg predicted body weight (based on sex and height, not actual weight) 1, 2, 3, 5
  • Maintain plateau pressure ≤30 cmH₂O 1, 2, 3, 6
  • Target SpO₂ no higher than 96% to avoid oxygen toxicity 1, 3

PEEP Strategy

  • For moderate to severe ARDS (PaO₂/FiO₂ <200 mmHg): Use higher PEEP strategy without prolonged lung recruitment maneuvers 1, 2, 3
  • Higher PEEP reduces mortality and improves oxygenation by preventing cyclic opening and closing of airspaces 2, 7
  • Strongly avoid prolonged lung recruitment maneuvers due to high probability of hemodynamic harm 1, 2
  • Monitor for barotrauma when using PEEP >10 cmH₂O, particularly in COVID-19 patients 1

Adjunctive Therapies for Severe ARDS (PaO₂/FiO₂ <100 mmHg)

Prone Positioning (Highest Priority)

  • Implement prone positioning for >12 hours daily (12-16 hours) in all patients with severe ARDS, as this intervention has demonstrated significant mortality reduction 1, 2, 3
  • Apply deep sedation and analgesia during prone positioning 3
  • This is a performance measure with proven mortality benefit and should not be delayed 2

Neuromuscular Blocking Agents

  • Consider cisatracurium infusion for 48 hours in early severe ARDS to improve ventilator synchrony and reduce oxygen consumption 1, 2, 3
  • Particularly beneficial when ventilator-patient dyssynchrony persists despite sedation 3

Corticosteroids

  • Administer systemic corticosteroids for ARDS, which has conditional support with moderate certainty of evidence 1, 2
  • Particularly recommended for COVID-19 ARDS, which has shown mortality benefit 1

Fluid Management

  • Implement conservative fluid management strategy to minimize pulmonary edema while maintaining adequate organ perfusion 1, 2, 3
  • Limit total crystalloid to <4000 mL in first 24 hours 2
  • Use non-aggressive resuscitation at 1.5 mL/kg/hr after initial 10 mL/kg bolus 2
  • Avoid fluid overload, which worsens oxygenation, promotes right ventricular failure, and increases mortality 1, 3

Advanced Rescue Therapies for Refractory Hypoxemia

Venovenous ECMO

  • Consider VV-ECMO in selected patients with severe ARDS (PaO₂/FiO₂ <100 mmHg) who fail conventional management, particularly those with reversible disease 1, 2, 3
  • Only implement at centers with ECMO expertise 3
  • Blood is pumped from femoral vein and returns to right atrium through internal jugular vein after membrane oxygenation 3

Inhaled Pulmonary Vasodilators

  • Consider a trial of inhaled pulmonary vasodilator as rescue therapy for severe hypoxemia despite optimized ventilation 1, 3
  • Discontinue if no rapid improvement in oxygenation 1, 3
  • Avoid routine use of inhaled nitric oxide 1, 6

Monitoring Requirements

  • Continuously monitor oxygen saturation, respiratory mechanics, and hemodynamics 1, 2, 3
  • Use echocardiography to assess right ventricular function and detect acute cor pulmonale in severe cases 1, 2, 3
  • Monitor fluid balance carefully 3
  • Assess for ventilator-patient dyssynchrony 3
  • Arterial blood gas analysis at 1-2 hours and again at 4-6 hours if initial improvement is minimal 3

Ventilator Weaning

  • Perform daily spontaneous breathing trials once the patient's condition improves, as this consistently reduces duration of mechanical ventilation 3
  • Use noninvasive ventilation after extubation for patients at high risk for extubation failure to reduce ICU length of stay and mortality 3

Critical Pitfalls to Avoid

  • Underutilization of prone positioning in severe ARDS is associated with increased mortality 2
  • Delaying intubation in deteriorating patients on noninvasive support 3
  • Using prolonged lung recruitment maneuvers with high PEEP 1, 2
  • Aggressive fluid resuscitation worsening pulmonary edema 2
  • Using tidal volumes >8 mL/kg predicted body weight 2, 5

References

Guideline

Management of Viral Acute Respiratory Distress Syndrome (ARDS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ARDS Management with Chest Contusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

ARDS Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fifty Years of Research in ARDS. Vt Selection in Acute Respiratory Distress Syndrome.

American journal of respiratory and critical care medicine, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.